Pre-emptive Quadratus Lumborum Block for Laparoscopic Bariatric Surgery

• Status: Completed
• Trial end date: 2020-03-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to determine the effectiveness of pre-emptive Quadratus lumborum block on intra, postoperative pain assessment and opioid requirements in laparoscopic bariatric procedures.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

Patients included in this study are

• Both genders

• Age between 18-50 years

• Those undergoing laparoscopic bariatric surgery (as laparoscopic sleeve gastrectomy or gastric bypass).

• BMI ≥ 35 Kg/m2 with comorbidity or ≥ 40 Kg/m2 without comorbidity.

Exclusion Criteria:

Patients excluded from this study were

• those with obstructive sleep apnoea and/or Pickwickian syndrome.

• if the laparoscopy procedure was converted to laparotomy.

• patients suffering from known coagulation defects.

• known hypersensitivity to bupivacaine, or those with contraindication to the use of NSAIDS.

• Presence of sepsis at the site of injection.